# Artiva Biotherapeutics, Inc.: Form SC 13D, filed Jul 29, 2024

- Company: [Artiva Biotherapeutics, Inc.](/companies/artv.md) (CIK 1817241)
- Form: SC 13D
- Filed: 2024-07-29
- Accepted by EDGAR: Jul 29, 2024, 16:29 ET
- Period: not reported
- Accession: 0001104659-24-083555
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1817241/000110465924083555/tm2420305d1_sc13d.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1817241/000110465924083555/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1817241/000110465924083555/tm2420305d1_sc13d.htm

Filed Jul 29, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-083555. Last ingested by Listed: Nov 3, 2026, 18:57 ET. No prices; not investment advice.